NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹674 Cr | ₹493 Cr | ₹322 Cr | ₹218 Cr | ₹181 Cr |
What is the latest Net Current Assets ratio of NEULAND LABORATORIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹674 Cr |
| Mar2024 | ₹493 Cr |
| Mar2023 | ₹322 Cr |
| Mar2022 | ₹218 Cr |
| Mar2021 | ₹181 Cr |
How is Net Current Assets of NEULAND LABORATORIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹674 Cr | 36.57 | |
| Mar2024 | ₹493 Cr | 53.26 | |
| Mar2023 | ₹322 Cr | 47.92 | |
| Mar2022 | ₹218 Cr | 20.19 | |
| Mar2021 | ₹181 Cr | - | |
Compare Net Current Assets of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹24,981.4 Cr | 3.2% | 13.7% | 57.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 3.2% |
13.7% |
57.3% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses